2-amino-1-(2-methyl-5-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenylcarbamoyl)phenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide

ID: ALA3321819

PubChem CID: 118409751

Max Phase: Preclinical

Molecular Formula: C30H23F3N8O2

Molecular Weight: 584.56

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cn(-c2cc(NC(=O)c3ccc(C)c(-n4c(N)c(C(N)=O)c5nc6ccccc6nc54)c3)cc(C(F)(F)F)c2)cn1

Standard InChI:  InChI=1S/C30H23F3N8O2/c1-15-7-8-17(29(43)37-19-10-18(30(31,32)33)11-20(12-19)40-13-16(2)36-14-40)9-23(15)41-26(34)24(27(35)42)25-28(41)39-22-6-4-3-5-21(22)38-25/h3-14H,34H2,1-2H3,(H2,35,42)(H,37,43)

Standard InChI Key:  JARLPBGMQYGJMW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 43 48  0  0  0  0  0  0  0  0999 V2000
    1.5698  -19.2196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2843  -18.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2843  -17.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5698  -17.5696    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8553  -17.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1408  -17.5696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5764  -17.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5764  -18.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1408  -19.2196    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8553  -18.8071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0689  -19.0620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0689  -17.7272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5539  -18.3946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3239  -16.9425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7718  -16.3294    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.1207  -16.7290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3239  -19.8466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7718  -20.4597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0268  -21.2444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8337  -21.4159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3857  -20.8028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1308  -20.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3789  -18.3946    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1928  -20.9743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4477  -21.7589    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2546  -21.9305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7448  -20.3613    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5064  -22.7160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3126  -22.8877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8656  -22.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6068  -21.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8012  -21.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5672  -23.6725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0148  -24.2853    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.3741  -23.8444    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.7792  -24.4668    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.9648  -20.2882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1540  -20.8706    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9748  -20.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3076  -20.1991    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6925  -19.6492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9797  -20.0643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7758  -18.8284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 12 13  2  0
 11 13  1  0
  2 11  1  0
  3 12  1  0
 14 15  2  0
 14 16  1  0
 12 14  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 17 22  2  0
 11 17  1  0
 13 23  1  0
 21 24  1  0
 24 25  1  0
 25 26  1  0
 24 27  2  0
 26 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 26  1  0
 29 33  1  0
 33 34  1  0
 33 35  1  0
 33 36  1  0
 18 37  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 38  1  0
 31 38  1  0
 41 43  1  0
M  END

Associated Targets(Human)

EPHA3 Tchem Ephrin type-A receptor 3 (1582 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EPHB4 Tchem Ephrin type-B receptor 4 (3198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 584.56Molecular Weight (Monoisotopic): 584.1896AlogP: 5.33#Rotatable Bonds: 5
Polar Surface Area: 146.74Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.93CX Basic pKa: 5.91CX LogP: 5.17CX LogD: 5.16
Aromatic Rings: 6Heavy Atoms: 43QED Weighted: 0.25Np Likeness Score: -1.69

References

1. Unzue A, Dong J, Lafleur K, Zhao H, Frugier E, Caflisch A, Nevado C..  (2014)  Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation.,  57  (15): [PMID:25076195] [10.1021/jm5009242]

Source